Leading the way to a cure

Lupus Research Update: 2009 Volume 4

Volume 4, 2009 - Online Edition | In This Issue

Thinking Outside of Boundaries >
Message from the President >
The ALR Holds Key Industry Workshop on Lupus Clinical Trials >
Faces of Lupus — Thanks to Walkers on our 10th Anniversary >
Jets Kick Off Season of Hope >
Take Advantage of Tax Benefits — Make Your Year-End Gift Today! >
A "Driving" Force for Lupus Research >
Good News from Lupus Clinical Trials >

The ALR Holds Key Industry Workshop on Lupus Clinical Trials

This past October, the ALR held an important two-day meeting in New York City: a gathering of pharmaceutical and biotech companies and some of the world's most informed scientists, rheumatologists, and clinical and research experts — including the ALR's Scientific Advisory Board. The objective: to examine the science behind lupus clinical trials from the vantage point of some of the instrumental players.

Representing the pharmaceutical and biotech companies were Amgen, Biogen Idec, Bristol-Myers Squibb, EMD Serono, Genentech and Roche, GlaxoSmithKline, Human Genome Sciences, and UCB. Each gave a presentation of its efforts to develop possible treatments for lupus.

Representatives from the pharmaceutical companies listed above shared their clinical trial findings at an ALR-sponsored meeting.

This forum was an ideal setting to exchange ideas and learn about what is working and what isn't in clinical trials. Even though outcomes have varied — with some trials failing and others moving forward — all are increasing our understanding of the disease and helping to direct future trials. Many topics were covered in rigorous discussions — especially the role of B-cells and T-cells in lupus and what the scientific community continues to learn about them through targeted research.

It's the ALR's hope that this meeting will set the tone for even better communication between the lupus scientific community and the companies that are working to develop drugs to treat lupus. The gathering also revealed what the ALR could do to further refine its important role in propelling critical research.

The ALR is proud to have orchestrated this significant meeting — and we thank all the participants for their willingness to share ideas — and for their ceaseless desire to help people with lupus better cope with the disease.

1.5 million

people in the U.S. have Lupus.

172 million

dollars committed to lupus research by the Lupus Research Alliance.

We're walking across the United States to raise awareness and funds for lupus research.


Show your support by visiting the Lupus Research Alliance online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Blackbaud
nonprofit software